Free Trial

'Lilo & Stitch' passes 'Sinners' to become 2nd highest grossing film of 2025

This image shows the character Stitch in a still from the film "Lilo & Stitch." (Walt Disney Studios Motion Pictures via AP)

Key Points

  • “Lilo & Stitch” led the weekend with $63 million in North America, surpassing “Sinners” to become the second-highest grossing film of 2025 with $280.1 million domestically and $610.8 million globally.
  • “Mission: Impossible – The Final Reckoning” repeated at No. 2 with $27.3 million (down 57% from its opening), pushing its global total to $353.8 million but still trailing against its $400 million production budget.
  • Sony’s “Karate Kid: Legends” debuted at No. 3 with $21 million from 3,809 locations, earning an A– CinemaScore and 4.5 stars on PostTrak, while costing just $45 million to produce and grossing $47 million internationally to date.
  • The post-Memorial Day weekend box office totaled $149 million—up over 120% year-over-year—with May on track to close at $973 million, a 75% increase from May 2024.
  • Interested in Hawkins? Here are five stocks we like better.

“Lilo & Stich” and “Mission: Impossible—The Final Reckoning” dominated the box office charts again after fueling a record-breaking Memorial Day weekend. Theaters in the U.S. and Canada had several new films to offer this weekend as well, including Sony’s family friendly “Karate Kid: Legends” and the A24 horror movie “Bring Her Back. ” According to studio estimates Sunday, it added up to a robust $149 million post-holiday weekend that’s up over 120% from the same timeframe last year.

Disney’s live-action hybrid “Lilo & Stitch” took first place again with $63 million from 4,410 locations in North America. It was enough to pass “Sinners” to become the second-highest grossing movie of the year with $280.1 million in domestic ticket sales. Globally, its running total is $610.8 million. “Sinners,” meanwhile, is still going strong in its seventh weekend with another $5.2 million, bumping it to $267.1 million domestically and $350.1 million globally.

The eighth “Mission: Impossible” movie also repeated in second place, with $27.3 million from 3,861 locations. As with “Lilo & Stitch,” that's down 57% from its opening. With $122.6 million in domestic tickets sold, it’s performing in line with the two previous installments. But with a reported production budget of $400 million, profitability is a ways off. Internationally, it added $76.1 million (including $25.2 million from China where it just opened), bringing its global total to $353.8 million.

“This is the year of longterm playability,” said Paul Dergarabedian, Comscore’s senior media analyst. “The currency of word of mouth and the strong hold is more important than opening weekend dollars.”

Leading the newcomers was Sony’s “Karate Kid: Legends,” with an estimated $21 million from 3,809 locations. The movie brings Jackie Chan and Ralph Macchio together to train a new kid, the kung fu prodigy Li Fong ( Ben Wang ). Chan starred in a 2010 reboot of the 1984 original, while Macchio has found a new generation of fans in the series “Cobra Kai,” which just concluded a six-season run.

Reviews might have been mixed, but opening weekend audiences gave the PG-13 rated film a strong A- CinemaScore and 4.5 stars on PostTrak. It also only cost a reported $45 million to produce and has several weeks until a new family-friendly film arrives. “Karate Kid: Legends” opened earlier internationally and has a worldwide total of $47 million.

Fourth place went “Final Destination: Bloodlines,” which earned $10.8 million in its third weekend. The movie is the highest-grossing in the franchise, not accounting for inflation, with $229.3 million globally.

The weekend’s other big newcomer, “Bring Her Back” rounded out the top five with $7.1 million from 2,449 screens. Starring Sally Hawkins as a foster mother with some disturbing plans, the film is the sophomore feature of twin filmmakers Danny and Michael Philippou, who made the 2023 horror breakout “Talk to Me.” It earned a rare-for-horror B+ CinemaScore and is essentially the only new film in the genre until “28 Years Later” opens on June 20.

A new Wes Anderson movie, “The Phoenician Scheme,” also debuted in New York and Los Angeles this weekend, where it made $270,000. It expands nationwide next weekend.

The summer box office forecast remains promising, though there’s a long way to go to get to the $4 billion target (a pre-pandemic norm that only the “Barbenheimer” summer has surpassed). The month of May is expected to close out with $973 million – up 75% from May 2024, according to data from Comscore.

Top 10 movies by domestic box office

With final domestic figures being released Monday, this list factors in the estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Comscore:

1. “Lilo & Stitch,” $63 million.

2. “Mission: Impossible – The Final Reckoning,” $27.3 million.

3. “Karate Kid: Legends,” 21 million.

4. “Final Destination: Bloodlines,” $10.8 million.

5. “Bring Her Back,” $7.1 million.

6. “Sinners,” $5.2 million.

7. “Thunderbolts,” $4.8 million.

8. “Friendship,” $2.6 million.

9. “The Last Rodeo,” $2.1 million.

10. “j-hope Tour ‘HOPE ON THE STAGE’ in JAPAN: LIVE VIEWING,” $939,173.

Should You Invest $1,000 in Hawkins Right Now?

Before you consider Hawkins, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.

While Hawkins currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines